Brigitte Elisabeth Sanders-Beer, Nancie M Archin, Zabrina L Brumme, Michael Busch, Claire Deleage, Una O'Doherty, Stephen H Hughes, Keith Jerome, R Brad Jones, Jonathan Karn, Mary F Kearney, Brandon Keele, Deanna Kulpa, Gregory Laird, Jonathan Z Li, Mathias Lichterfeld, Michel C Nussenzweig, Deborah Persaud, Steven Yukl, Robert F Siliciano, John W Mellors
Since the first HIV-cured person was reported in 2009, a strong interest in developing highly sensitive HIV and SIV reservoir assays has emerged. In particular, the question arose about the comparative value of state-of-the-art assays to measure and characterize the HIV reservoir, and how these assays can be applied to accurately detect changes in the reservoir during efforts to develop a cure for HIV infection. Secondly, it is important to consider the impact on the outcome of clinical trials if these relatively new HIV reservoir assays are incorporated into clinical trial endpoints and/or used for clinical decision-making...
April 26, 2023: AIDS Research and Human Retroviruses